Moneycontrol PRO
HomeNewsDrreddyslaboratories

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Here are top 10 stocks to focus on January 13

    Here are top 10 stocks to focus on January 13 - Cairn India, Jet Airways, Apollo Tyres, Ceat, Crompton Greaves, Bank Nifty, Hindalco, CMC, Clariant Chemicals and Spicejet. We are also watching Dr Reddy's, Sun Pharma, Ipca Labs, Lupin, Cipla, ACC and Ultratech.

  • Buy Dr Reddy's 3200 Put, sell 3000 Put: Krish Subramanyam

    Krish Subramanyam of Asit C Mehta Investment Intermediates recommends buying Dr Reddy's Laboratories 3200 Put and sell 3000 Put.

  • Here are top 10 stocks to focus on January 1

    Here are top 10 stocks to focus on January 1 - HPCL, Maruti, ICICI Bank, Axis Bank, Dr Reddy's, HCL Tech, Bharti Airtel, Marico, Adani Ports & Rallis India.

  • Prefer Dr Reddy's Laboratories, says Sukhani

    According to Sudarshan Sukhani of s2analytics.com, one may prefer Dr Reddy's Laboratories.

  • Avoid IT, pharma space: Andrew Holland

    Andrew Holland of Ambit Investment is of the view that one may avoid IT, pharma and consumer space.

  • Pick Dr Reddy's Laboratories: Phani Sekhar

    Phani Sekhar of Angel Broking is of the view that one may pick Dr Reddy's Laboratories.

  • Avoid Dr Reddy's Laboratories: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may avoid Dr Reddy's Laboratories.

  • Buy Dr Reddy‘s Laboratories, says Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com advises buying Dr Reddy‘s Laboratories.

  • Prefer Asian Paints for long term: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Asian Paints for long term.

  • Here are top 10 stocks to keep an eye on December 17

    Here are top 10 stocks to keep an eye on December 17 - Infosys, Zee Entertainment, Tata Steel, Dr Reddy's, Jagran Prakashan, Reliance Capital, Bharti Airtel, UPL, HCL Tech and TCS.

  • Here are top 10 stocks to focus on December 15

    Here are top 10 stocks to focus on December 15 – Mahindra and Mahindra (M&M), HCL Technologies, India Cement, Gas Authority of India (GAIL), Tata Consultancy Services (TCS), Bank Nifty, Dr Reddy's, Glenmark, Havells and SpiceJet.

  • Book profits in Alembic: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com recommends booking profits in Alembic and advises switching to Sun Pharma or Dr Reddy's Labs.

  • Here are top 10 stocks to focus on December 4

    Here are top 10 stocks to focus on December 4 - Ashok Leyland, Apollo Tyres, NBCC, HDFC Bank, ICICI Bank, MBL Infra, SAIL, Ranbaxy, Dr Reddy's and Sadbhav Engineering.

  • Sun Pharma, Lupin, Dr Reddy's preferred picks: Agarwal

    According to Nitin Agrawal - Pharma Analyst at IDFC Securities, Sun Pharma, Lupin and Dr Reddy's labs are the preferred picks.

  • Buy Dr Reddy's, Aurobindo Pharma: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Laboratories and Aurobindo Pharma.

  • Buy Dr Reedy's Labs 3500 call: VK Sharma

    VK Sharma of HDFC Securities recommends buying Dr Reddy's Laboratories 3500 Call.

  • Bullish on pharma; buy Lupin, Dr Reddys, Ipca: JM Financial

    For the largecap pharma companies the game has become completely US-cued. So, US will be the driver for Dr Reddys and Lupin, says Anmol Ganjoo.

  • Ranbaxy may suffer loss of $250 mn on approval woes: Expert

    Surajit Pal, pharma analyst, Prabhudas Lilladher, expects Teva, Mylan, Sandoz and Dr Reddy‘s Laboratories to benefit from this loss.

  • YES Bank attractive bet: Mayuresh Joshi

    Mayuresh Joshi, VP- Institution at Angel Broking is of the view that YES Bank, LIC Housing Finance and Infosys are attractive bets.

  • Buy L&T, Bharat Forge, Dr Reddy's Labs: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com recommends buying Bharat Forge, Larsen and Toubro and Dr Reddy's Laboratories.

  • Buy Dr Reddy's Labs, State Bank of India: Yogesh Mehta

    Yogesh Mehta of Motilal Oswal recommends buying State Bank of India and Dr Reddy's Laboratories.

  • Accumulate Dr Reddy's Laboratories: Phani Sekhar

    Phani Sekhar of Angel Broking recommends accumulating Dr Reddy's Laboratories for long term.

  • Buy Dr Reddys Lab, Glenmark Pharma: Sukhani

    According to Sudarshan Sukhani of s2analytics.com, one may buy Dr Reddys Laboratories and Glenmark Pharma.

  • Super Six stocks you can bet on October 22

    Manas Jaiswal of manasjaiswal.com recommends buying IRB Infra with a target of Rs 254 and NHPC with a target of Rs 21.

  • Krish Subramanyam advises bull spread in Dr Reddy's Labs

    Krish Subramanyam of Asit C Mehta Inv Intermediates recommends bull spread in Dr Reddy's Laboratories wherein one can buy 3000 call and sell 3200 call.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347